Company Neurotech International Limited

Equities

NTI

AU000000NTI9

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Medical Monitoring Systems

Market Closed - Australian S.E. Other stock markets 11:40:42 02/05/2024 am IST			5-day change	1st Jan Change
0.091 ^AUD	0.00%		+1.11%	+31.88%

17/04	Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint	MT
17/04	Neurotech International Completes AU$10 Million Capital Raise	MT

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused on the development and commercialization of neurological solutions focused predominately on pediatric neurological disorders. The Company conducts clinical studies to assess the neuro-protective, anti-inflammatory, and neuro-modulatory activities of its NTI/Dolce cannabis strains. It is also commercializing Mente, a home therapy to increase engagement and improve relaxation in autistic children with elevated delta-band brain activity. Its product, Mente Autism, assists with the management of children with autism spectrum disorder (ASD). Its development program NTI164 completed a Phase I/II clinical trial to treat patients with autism spectrum disorder (ASD). Mente Autism is a portable, electroencephalographic (EEG) medical device for home use in the form of a headband that uses closed-loop neurofeedback to helo-relax the minds of children with ASD.

AUD in Million	2022	Weight	2023	Weight	Delta
Medical Device Development and Distribution 100.0 %	0	100.0 %	0	100.0 %	-84.43%

AUD in Million	2022	Weight	2023	Weight	Delta
Malta 100.0 %	0	100.0 %	0	100.0 %	-84.43%

Managers	Title	Age	Since
Alexandra Andrews COO	Chief Operating Officer	-	08/22/08
Erlyn Dawson SEC	Corporate Secretary	-	16/19/16

Members of the board	Title	Age	Since
Mark Davies CHM	Chairman	-	16/19/16
Thomas Duthy BRD	Director/Board Member	-	01/22/01
Gerald Quigley BRD	Director/Board Member	-	07/22/07

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	891,739,236	698,149,561 ( 78.29 %)	0	78.29 %

Name	Equities	%	Valuation
Merchant Funds Management Pty Ltd. 7.123 %	65,344,330	7.123 %	5 M $
Robert Johnston 0.0363 %	333,333	0.0363 %	23 920 $

Neurotech International Ltd.

145 Stirling Highway Suite 5 CPC

6009, Nedlands

http://www.neurotechinternational.com

address Neurotech International Limited(NTI)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Monitoring Systems

	1st Jan change	Capi.
NEUROTECH INTERNATIONAL LIMITED	+31.88%	60.56M
IRHYTHM TECHNOLOGIES, INC.	-4.07%	3.45B
EKF DIAGNOSTICS HOLDINGS PLC	-5.53%	169M
MEDIANA CO.,LTD	-14.17%	83.57M

Medical Monitoring Systems